Marko Bergovec
Overview
Explore the profile of Marko Bergovec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Brcic I, Scheipl S, Bergovec M, Leithner A, Szkandera J, Sotlar K, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555836
In the last decade, new tumor entities have been described, including -rearranged neoplasms of different biologic behavior. To gain further insights into the behavior of these tumors, we analyzed a...
12.
High complication rate with titanium plates for chest wall reconstruction following tumour resection
Bergovec M, Smolle M, Lindenmann J, Fediuk M, Leithner A, Smolle-Juttner F
Eur J Cardiothorac Surg
. 2022 Nov;
62(6).
PMID: 36370073
Objectives: The reconstruction of the chest wall defect after tumour resection presents a challenge. Titanium rib plates were presented as a reconstruction option due to its biocompatibility, flexibility and pliability....
13.
Smolle M, Bergovec M, Scheipl S, Gossler W, Amerstorfer F, Glehr M, et al.
Sci Rep
. 2022 Jul;
12(1):13041.
PMID: 35906279
Silver-coated megaprostheses are considered to reduce infection rate following reconstruction of bone defects in tumour surgery or revision arthroplasty. However, little is known about systemic silver exposure and possible side...
14.
Smolle M, Musser E, Bergovec M, Friesenbichler J, Wibmer C, Leitner L, et al.
Cancers (Basel)
. 2022 Jul;
14(14).
PMID: 35884582
Introduction: The aim of this study was to externally validate the 2013-SPRING model, a survival prediction tool for patients treated surgically for bone metastases in a retrospective patient cohort from...
15.
Smolle M, Gilg M, Machacek F, Smerdelj M, Tunn P, Mavcic B, et al.
Wien Klin Wochenschr
. 2021 Nov;
134(11-12):434-441.
PMID: 34735614
Background: Osteoid osteomas of the foot are rare, with a varying and atypical clinical as well as radiological presentation impeding early diagnosis and treatment. The aim of the present multicentre...
16.
Scheipl S, Brcic I, Moser T, Fischerauer S, Riedl J, Bergovec M, et al.
Ther Adv Med Oncol
. 2021 Aug;
13:17588359211029125.
PMID: 34367342
Background: Molecular diagnosis has become an established tool in the characterisation of adult soft-tissue sarcomas (STS). FoundationOne Heme analyses somatic gene alterations in sarcomas DNA and RNA-hotspot sequencing of tumour-associated...
17.
Amerstorfer F, Igrec J, Valentin T, Leithner A, Leitner L, Glehr M, et al.
Acta Orthop
. 2021 Jun;
92(6):753-759.
PMID: 34165046
Background and purpose - Cat scratch disease (CSD) is a self-limiting disease caused by It is characterized by granulomatous infection, most frequently involving lymph nodes. However, it can present with...
18.
Smolle M, Herbsthofer L, Granegger B, Goda M, Brcic I, Bergovec M, et al.
Br J Cancer
. 2021 Jun;
125(5):717-724.
PMID: 34127811
Background: Soft tissue sarcomas (STS) are generally considered non-immunogenic, although specific subtypes respond to immunotherapy. Antitumour response within the tumour microenvironment relies on a balance between inhibitory and activating signals...
19.
Smolle M, van de Sande M, Hayes A, Bergovec M, Smith H, Liegl-Atzwanger B, et al.
Eur J Surg Oncol
. 2021 Apr;
47(8):2182-2188.
PMID: 33865657
Background: The updated 8th version of the AJCC-staging system for soft tissue sarcomas (STS) has been criticised for omitting tumour depth as category-defining variable and eventually not improving prognostic accuracy...
20.
Basharkhah A, Lackner H, Karastaneva A, Bergovec M, Spendel S, Castellani C, et al.
Front Pediatr
. 2021 Apr;
9:661025.
PMID: 33791262
Ewing sarcomas of the chest wall, historically known as "Askin tumors" represent highly aggressive pediatric malignancies with a reported 5-year survival ranging only between 40 and 60% in most studies....